Enantiomerically pure beta -D-dioxolane-nucleosides

摘要

A method and composition for the treatment of humans infected with HIV that includes the administration of an HIV treatment amount of an enantiomerically pure beta -D-dioxolanyl purine nucleoside of the formula: wherein R is OH, Cl, NH2, or H, or a pharmaceutically acceptable salt or derivative of the compound, optionally in a pharmaceutically acceptable carrier or diluent.